SF News Global Supplement News Engine
Regulation

India Mandates HACCP and GMP for FBO Licensing, Strengthening Supply Chain Oversight

The FSSAI in India reinforces mandatory HACCP and GMP compliance under Schedule 4 for all food business operators seeking licenses, directly impacting manufacturing and supply chain costs.

AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →

Regulation concept image

New Delhi, India — 18 March 2026

The Food Safety and Standards Authority of India (FSSAI) is rigorously enforcing compliance with its Food Safety Management System (FSMS) framework, making Hazard Analysis and Critical Control Point (HACCP) principles and suitable prerequisite programmes non-negotiable for food business operators (FBOs) applying for licensing. This directive, outlined within the FSS (Licensing & Registration of Food Businesses) Regulations 2011, specifically under Schedule 4, requires FBOs to demonstrate active control of hazards across their entire food chain, from production to final consumption.

The mandate signifies a tightening of regulatory expectations for all entities involved in food and supplement manufacturing, processing, packaging, storage, and distribution in India. FBOs are now explicitly required to possess a documented FSMS plan at the point of license application. This plan must articulate adherence to Good Manufacturing Practices (GMP) and Good Hygiene Practices (GHP), as detailed across five distinct parts of Schedule 4, which categorise requirements by operational type: petty FBOs/street vendors, manufacturing/processing, milk/milk products, slaughterhouses/meat processing, and catering services.

The emphasis on FSMS implementation, rooted in HACCP, aims to elevate food safety standards nationally. For supplement manufacturers and ingredient suppliers operating within or exporting to India, this translates into direct operational costs associated with system development, documentation, staff training, and potential infrastructure upgrades to meet the stringent GHP/GMP benchmarks specified in Schedule 4. Manufacturers must view these as baseline requirements, not aspirational goals, to maintain market access and avoid regulatory penalties.

What this means for India

Indian supplement manufacturers and brand owners face immediate pressure to review and update their FSMS documentation and operational protocols. Compliance with Schedule 4 is a condition of license, meaning any deficiencies can halt new product introductions or existing operations. Procurement leads must verify supplier adherence to these refreshed standards, as non-compliant raw material sources could compromise finished product regulatory standing. This regulatory environment creates a competitive advantage for compliant-ready businesses, while others face significant reformulation windows, extended lead times for necessary certifications, and potential market share erosion due to delays in license renewals or new market entries. Investment in robust quality assurance teams and external compliance auditing services becomes critical.

What to watch next

  • The FSSAI is expected to issue updated guidance documents or webinars by Q3 2024 to clarify specific compliance pathways for smaller FBOs and novel food categories under Schedule 4.
  • Increased FSSAI inspection frequency focusing on documented FSMS plans and on-site implementation of GHP/GMP will likely commence from Q1 2025, potentially leading to more license suspensions.

For more on UK formulation and manufacturing best practice, learn more at Supplement Factory.